Drawing for PERCHERON

USPTO serial 79392666

PERCHERON

Reviewed by CopyMark Law Group

Reg. 7862415Status 700Registered
Filing date
Status date
Registration date
Jul 15, 2025
Examiner
VELTEN, MALLORY KATE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PERCHERON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Frederick H. Colen

Frederick H. Colen The Webb Law Firm420 Ft. Duquesne Blvd., Suite 1200One Gateway CenterPittsburgh, PA 15222

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of rare neurological diseases and cancer, excluding pharmaceuticals for horses and pharmaceuticals for the treatment of an artery of PercheronACTIVE
035Business intermediary services relating to the commercializing of goods, namely, negotiation of commercial transactions for third parties in the field of pharmaceuticalsACTIVE
042Scientific research in the nature of conducting clinical trials for others; medical and scientific research, namely, conducting clinical trials for others; biotechnology research, namely, biotechnology testing; scientific research relating to pharmaceuticals; pharmaceutical research services; services for assessing the efficiency of pharmaceuticals, namely, testing of pharmaceuticals; services for assessing the safety of pharmaceuticals, namely, testing of pharmaceuticals; all of the aforesaid excluding services for the treatment of an artery of PercheronACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 26, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Feb 6, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB
Feb 5, 2026FIMPFINAL DISPOSITION PROCESSED
Oct 30, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Oct 15, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 27, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 18, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Aug 27, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 27, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 15, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 15, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 27, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 27, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 21, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 23, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 24, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 24, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 21, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 21, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 19, 2024RFNTREFUSAL PROCESSED BY IB
Oct 2, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 2, 2024RFRRREFUSAL PROCESSED BY MPU
Sep 28, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 27, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2024RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Sep 22, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 21, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2024DOCKASSIGNED TO EXAMINER
Apr 6, 2024MAFRAPPLICATION FILING RECEIPT MAILED
Apr 2, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 28, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance